1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > 2016-2020 US Tumor Markers Diagnostic Testing Market: Supplier Shares by Test, and Market Segment Sales Forecasts

This report provides an overview of the US cancer diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Table of Contents

Business Environment

  1. Health Care Expenditures
  2. Cost Consciousness
  3. Industry Consolidation
  4. Managed Care
  5. Hospitals
  6. Admissions
  7. Length of Stay
  8. Industry Diversification
  9. Physician Demographics
10. Population Aging
      a. Chronic Illness
      b. Disease Incidence
      c. Susceptibility to Iatrogenesis
      d. Multiple Illness Cases
11. Laboratory Regulations

Market Structure

  1. Centralized Testing
      a. Hospitals
      b. Commercial/Private Laboratories
  2. Decentralized Testing
      a. Physician Offices/Group Practices
      b. Cancer Clinics
      c. Point-of-Care Testing
      d. Other Decentralized Testing Locations

Market Size, Growth, and Major Suppliers' Market Shares

List of Tables

Test Volume Forecasts by Market Segment

Sales Forecasts by Market Segment

AFP Testing: Market Shares of Major Suppliers

CA 15-3/27-29 Testing: Market Shares of Major Suppliers

CA 19-9 Testing: Market Shares of Major Suppliers

CEA Testing: Market Shares of Major Suppliers

PSA Testing: Market Shares of Major Suppliers

Contains 40 pages and 7 tables

Table Of Contents

2016-2020 US Tumor Markers Diagnostic Testing Market: Supplier Shares by Test, and Market Segment Sales Forecasts
The US Cancer Diagnostic Testing Market:
Sales Forecasts by Market Segment and Supplier Shares by Test
Table of Contents
Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
Market Structure
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Cancer Clinics
c. Point of Care Testing
d. Other Decentralized Testing Locations
Market Size, Growth, and Major Suppliers' Market Shares
List of Table
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
List of Table (Continued)
AFP Testing: Market Shares of Major Suppliers
CA 15-3/27-29 Testing: Market Shares of Major Suppliers
CA 19-9 Testing: Market Shares of Major Suppliers
CEA Testing: Market Shares of Major Suppliers
PSA Testing: Market Shares of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.